Novartis India received the Reader's Digest Pegasus CSR Gold Award in Mumbai on December 12. The award, in the "Contribution to individual welfare" category, recognizes the work the company has done in rehabilitating leprosy patients in India... Since 2000, Novartis has worked with the World Health Organization to provide free Multi-Drug Therapy treatment for all leprosy patients in the world through the end of 2010. This has led to the cure of 4.5 million patients so far. The Novartis Comprehensive Leprosy Care Association (NCLCA), a project sponsored by NFSD and Novartis India, helps recovering leprosy patients with both physical and social rehabilitation, including income generation assistance.